International Journal of Vascular Medicine最新文献

{"title":"Systematic Review and Meta: Analysis of Aortic Graft Infections following Abdominal Aortic Aneurysm Repair.","authors":"O S Niaz,&nbsp;A Rao,&nbsp;D Carey,&nbsp;J R Refson,&nbsp;A Abidia,&nbsp;P Somaiya","doi":"10.1155/2020/9574734","DOIUrl":"https://doi.org/10.1155/2020/9574734","url":null,"abstract":"<p><p><i>Introduction</i>. Aortic graft infection (AGI) is a rare complication following AAA repair and is associated with high morbidity and mortality. Management is variable, and there are no evidence-based guidelines. The aim of this study was to systematically review and analyse management options for AGI.</p><p><strong>Methods: </strong>Data was collected between July and August 2018. A full HDAS search was conducted on the following databases: MEDLINE, EMBASE, CINAHL, and PUBMED. Meta-analysis was conducted using RevMan 5 software.</p><p><strong>Results: </strong>1,365 patient outcomes were assessed (10 cohort studies and 12 comparative studies). The most common treatment was in situ replacement of the graft (ISR) followed by extra-anatomical replacement (EAR). Various grafts were used for ISR, such as fresh/cryopreserved allograft, venous graft, and prosthetic grafts. No graft material was shown to be superior. Axillobifemoral graft was the commonest type of EAR used. In the majority of cohort studies, ISR was the main treatment for AGI. There was no significant difference in the overall mortality rate (ISR <i>n</i> = 70/176 vs. EAR <i>n</i> = 70/176 vs. EAR <i>P</i> = 0.87). Graft occlusion rate was significantly lower in the ISR group vs. the EAR group (<i>n</i> = 70/176 vs. EAR <i>n</i> = 70/176 vs. EAR <i>P</i> = 0.87). Graft occlusion rate was significantly lower in the ISR group vs. the EAR group (<i>n</i> = 70/176 vs. EAR <i>n</i> = 70/176 vs. EAR <i>P</i> = 0.87). Graft occlusion rate was significantly lower in the ISR group vs. the EAR group (<i>Discussion</i>. In situ replacement is the preferred method of treatment as it had lower rates of occlusion. Further strong evidence is required, such as a multicentre trial to establish a management pathway for the condition.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2020 ","pages":"9574734"},"PeriodicalIF":1.3,"publicationDate":"2020-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/9574734","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37766815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mechanical Occlusion Chemically Assisted Ablation (MOCA) for Saphenous Vein Insufficiency: A Meta-Analysis of a Randomized Trial.","authors":"Johanes Nugroho, Ardyan Wardhana, Cornelia Ghea","doi":"10.1155/2020/8758905","DOIUrl":"10.1155/2020/8758905","url":null,"abstract":"<p><strong>Purpose: </strong>A previous meta-analysis has conducted nonrandomized trials for mechanochemical ablation (MOCA). Since medium-term follow-up data from randomized clinical trials (RCTs) are becoming available, we chose to perform a meta-analysis of RCTs to assess the efficacy and safety of MOCA for saphenous vein insufficiency.</p><p><strong>Methods: </strong>A systematic search of all RCTs comparing the anatomical success of MOCA for saphenous vein insufficiency to thermal ablation was performed using the PubMed and Cochrane Library databases. We employed the Mantel-Haenszel random-effects meta-analysis of outcomes using RevMan 5.3.</p><p><strong>Results: </strong>Four studies (615 patients) were included in this meta-analysis. The MOCA group had 93.4% and 84.5%, whereas the thermal ablation group had 95.8% and 94.8% of anatomical success rate at 1 month (short-term) and a period of more than 6 months but less than 1-year follow-up (mid-term), respectively. According to intention-to-treat analysis, there were similar anatomical successes in MOCA and thermal ablation groups at the short-term follow-up (low-quality evidence; relative risk (RR) = 0.98 (95% CI, 0.94-1.03); <i>P</i> = 0.44; <i>I</i> ² = 53%). The estimated effect of MOCA on anatomical success showed a statistically significant reduction at the mid-term follow-up (moderate-quality evidence; RR = 0.89 (95% CI, 0.84-0.95); <i>P</i> = 0.0002; <i>I</i> ² = 0%). MOCA had fewer incidence of nerve injury, deep vein thrombosis, and skin burns compared to the thermal ablation procedure (low-quality evidence; RR = 0.33 (95% CI, 0.09-1.28); <i>P</i> = 0.11; <i>I</i> ² = 0%).</p><p><strong>Conclusion: </strong>MOCA offered fewer major complications but lesser anatomical success at the period of more than 6 months but less than 1-year follow-up than thermal ablation. <i>Trial Registration</i>. This trial is registered with UMIN Clinical Trial Registry (UMIN ID 000036727).</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2020 ","pages":"8758905"},"PeriodicalIF":1.3,"publicationDate":"2020-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204279/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37938065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hypothermia during Surgical Treatment of Type A Aortic Dissection: A 16 Years' Experience.","authors":"Francesco Macrina,&nbsp;Maria Cristina Acconcia,&nbsp;Luigi Tritapepe,&nbsp;Mizar D'abramo,&nbsp;Wael Saade,&nbsp;Alessandra Capelli,&nbsp;Fabio Miraldi","doi":"10.1155/2020/3893261","DOIUrl":"https://doi.org/10.1155/2020/3893261","url":null,"abstract":"<p><p>Acute aortic dissection (AAD) is among the most challenging cases for surgical treatment and requires procedural expertise for its safe conduct. Aortic surgery has undergone several changes over the last years, especially concerning cerebral protection. The brilliant results obtained with the aid of selective anterograde cerebral perfusion led to a progressive increase of circulatory arrest temperature, with the rise of safe time along with a reduction of the extracorporeal circulation time and hypothermia-related side effects. However, there is still no definitive consensus concerning the optimal range of temperature to be used during circulatory arrest. <i>Objectives.</i> This is a retrospective observational study, and we examined 16-year trends in the presentation, diagnosis, hospital outcome and treatment of A AAD type. In our Cardiac Surgery Unit in Policlinico Umberto I of Rome, our analysis focused on patients, who received ACP during aortic surgery and we analyzed the differences between two distinct groups based on the lowest temperature reached during CPB conduction: Lower Temperature Group (LT) (<i>T</i> < 24°C) versus Higher Temperature Group (HT) (<i>T</i> ≥ 24°C) arrest circulation temperature. <i>Methods.</i> Data from 241 patients enrolled between August 2002 and March 2018 were analyzed. Patients were divided according to the lowest temperature reached into 2 groups: Lower Temperature group (LT) (94 patients) and Higher Temperature Group (HT) (147 patients). <i>Results.</i> Our results showed a significant reduction of in-hospital mortality and in-hospital results in patients with higher CPB temperature. The global incidence of complications was statistically reduced in HT group: we found a statistical significant reduction of intestinal ischemia, and a similar trend also for other complications analyzed, such as infections. Since the two groups were similar for type of surgical procedures, we considered these differences depending on the lower temperature value reached, according to the current literature. Conclusions. We found a significantly higher mortality in patients with lower temperature during CPB and a global reduction of complications and in particular a significant reduction of intestinal ischemia in patients with higher temperature during CPB. We found a similar trend in other fields of investigations, so we can conclude that circulatory arrest performed at temperature ≥24°C nasopharyngeal temperature associated with ACP is a safe strategy for aortic surgery for AAD.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2020 ","pages":"3893261"},"PeriodicalIF":1.3,"publicationDate":"2020-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/3893261","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39292103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Experience in the Management of Patients with Chronic Vascular Ulcers of the Lower Limbs Using Negatively Charged Polystyrene Microspheres.","authors":"María Teresa Cacua Sánchez","doi":"10.1155/2020/3673657","DOIUrl":"10.1155/2020/3673657","url":null,"abstract":"<p><strong>Background: </strong>Chronic ulcers of the lower limbs are a socioeconomic health problem, having a high incidence in the adult population. Despite a correct etiological treatment, in addition to the multiple lesion management options available, healing percentage and speed remain low, which makes it a great therapeutic challenge.</p><p><strong>Objective: </strong>To describe the outcome and effectiveness of the use of PolyHeal® Micro in the granulation and epithelialization of chronic ulcers of the lower limbs.</p><p><strong>Methods: </strong>Descriptive observational case series of 19 patients with diagnosis of chronic vascular ulcers of the lower limbs, treated at Medical Center Nuestra IPS and Medical Center Juan Pablo II in Bogotá between March 2018 and December 2018, who received PolyHeal® Micro as topical treatment for their lesions. Patients were assessed taking into account age, sex, ulcer size, pain, wound exudate, as well as granulation and epithelialization response.</p><p><strong>Results: </strong>In this series, the mean age of patients was 67.9 years, they were mostly females (84%), and the most common location of ulcers was the internal malleolus (50%). In terms of wound severity, 47% were found to be severe, 43% moderate, and 10% mild. The median time of lesion onset was 28 weeks, with a maximum of 2080 and a minimum of 8 weeks. In total, 87% of the ulcers were of venous etiology. After 12 weeks of treatment with Polyheal, ulcers showed a significative improvement of Wollina score means: 0.80 ± 0.90-5.90 ± 1.47; (<i>p</i> < 0.000). Wound area mean at the start of treatment was 31.6 cm², and at the end of treatment was 17.85 cm², which is equivalent to a wound area surface reduction of 54.2%, with a statistically significant <i>p</i> value. The interquartile range showed a reduction of 64.3% in the central means of wounds. Seventy percent of the patients reached a granulation percentage greater than 70%, 17% of the lesions exhibited an improvement of 30-70%, and there was an overall granulation improvement in 87% of the patients. Concerning epithelialization, 40% of patients reached a percentage higher than 70%, and 17% of patients between 30% and 70%. Treatment time was 12 weeks in 68% of cases, with an average response time of 8.1 weeks. Based on the visual analogue scale (VAS), a reduction in patients' perception of pain was achieved, dropping from an average of 6 (moderate to severe pain) to 2 (little pain), demonstrating an improvement in this regard. Fifty percent of the ulcers showed decreased exudate, resulting in a dry state. The patient satisfaction rate at the end of treatment was 89%.</p><p><strong>Conclusion: </strong>The use of PolyHeal® Micro for an average of 8.1 weeks of treatment showed a high rate of granulation and epithelialization in chronic ulcers of the lower limbs, improving pain perception in these patients and generating a high degree of treatment satisfaction.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2020 ","pages":"3673657"},"PeriodicalIF":1.3,"publicationDate":"2020-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/3673657","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37938063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Relationship between Military Combat and Cardiovascular Risk: A Systematic Review and Meta-Analysis.","authors":"Christopher J Boos,&nbsp;Norman De Villiers,&nbsp;Daniel Dyball,&nbsp;Alison McConnell,&nbsp;Alexander N Bennett","doi":"10.1155/2019/9849465","DOIUrl":"https://doi.org/10.1155/2019/9849465","url":null,"abstract":"<p><strong>Background and objectives: </strong>Cardiovascular disease (CVD) is a leading cause of death among military veterans with several reports suggesting a link between combat and related traumatic injury (TI) to an increased CVD risk. The aim of this paper is to conduct a widespread systematic review and meta-analysis of the relationship between military combat ± TI to CVD and its associated risk factors.</p><p><strong>Methods: </strong>PubMed, EmbaseProQuest, Cinahl databases and Cochrane Reviews were examined for all published observational studies (any language) reporting on CVD risk and outcomes, following military combat exposure ± TI versus a comparative nonexposed control population. Two investigators independently extracted data. Data quality was rated and rated using the 20-item AXIS Critical Appraisal Tool. The risk of bias (ROB using the ROBANS 6 item tool) and strength of evidence (SOE) were also critically appraised.</p><p><strong>Results: </strong>From 4499 citations, 26 studies (14 cross sectional and 12 cohort; 78-100% male) met the inclusion criteria. The follow up period ranged from 1 to 43.6 years with a sample size ranging from 19 to 621901 participants in the combat group. Combat-related TI was associated with a significantly increased risk for CVD (RR 1.80: 95% CI 1.24-2.62; <i>I</i> ² = 59%, <i>p</i> = 0.002) and coronary heart disease (CHD)-related death (risk ratio 1.57: 95% CI 1.35-1.83; <i>I</i> ² = 0%, <i>p</i> = 0.77: <i>p</i> < 0.0001), although the SOE was low. Military combat (without TI) was linked to a marginal, yet significantly lower pooled risk (low SOE) of cardiovascular death in the active combat versus control population (RR 0.90: CI 0.83-0.98; <i>I</i> ² = 47%, <i>p</i> = 0.02). There was insufficient evidence linking combat ± TI to any other cardiovascular outcomes or risk factors.</p><p><strong>Conclusion: </strong>There is low SOE to support a link between combat-related TI and both cardiovascular and CHD-related mortality. There is insufficient evidence to support a positive association between military combat ± any other adverse cardiovascular outcomes or risk factors. Data from well conducted prospective cohort studies following combat are needed.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2019 ","pages":"9849465"},"PeriodicalIF":1.3,"publicationDate":"2019-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/9849465","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37540619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effects of Vitamin C on the Prevention of Ischemia-Reperfusion Brain Injury: Experimental Study in Rats.","authors":"Kelston Paulo Felice de Sales,&nbsp;Bruno Araújo Serra Pinto,&nbsp;Nathalee Liberal Xavier Ribeiro,&nbsp;Thamys Marinho Melo,&nbsp;Leonardo Victor Galvão-Moreira,&nbsp;Sebastião Barreto de Brito Filho,&nbsp;Flávio Nigri","doi":"10.1155/2019/4090549","DOIUrl":"https://doi.org/10.1155/2019/4090549","url":null,"abstract":"<p><strong>Background: </strong>Reperfusion syndrome after carotid endarterectomy is a complication associated with cerebrovascular self-regulation in a chronically hypoperfused cerebral hemisphere, leading to severe neurological damage. Vitamin C is an important antioxidant in brain metabolism that has shown some neuroprotective actions.</p><p><strong>Objective: </strong>To investigate the potential effects of vitamin C on cerebral reperfusion in comparison with placebo (saline) in rats.</p><p><strong>Methods: </strong>Male Wistar rats were divided into 3 groups: (i) Sham (<i>n</i> = 4), animals exposed to carotid arteries dissection without clamping; (ii) Control (<i>n</i> = 4), animals exposed to carotid arteries dissection without clamping; (ii) Control (<i>n</i> = 4), animals exposed to carotid arteries dissection without clamping; (ii) Control (.</p><p><strong>Results: </strong>Rats treated with vitamin C presented with a similar behavior as compared to the Sham group in all the three tests (<i>p</i> > 0.05), but it was significantly different from controls (<i>p</i> > 0.05), but it was significantly different from controls (<i>p</i> > 0.05), but it was significantly different from controls (.</p><p><strong>Conclusion: </strong>In the present study, vitamin C was associated with behavioral and motor preservation as well as decreased cerebral MDA levels after induced cerebral ischemia in rats.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2019 ","pages":"4090549"},"PeriodicalIF":1.3,"publicationDate":"2019-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/4090549","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37670307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Corrigendum to \"Caffeine's Vascular Mechanisms of Action\".","authors":"Darío Echeverri,&nbsp;Félix R Montes,&nbsp;Mariana Cabrera,&nbsp;Angélica Galán,&nbsp;Angélica Prieto","doi":"10.1155/2019/7480780","DOIUrl":"https://doi.org/10.1155/2019/7480780","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1155/2010/834060.].</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2019 ","pages":"7480780"},"PeriodicalIF":1.3,"publicationDate":"2019-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/7480780","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37670312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Short Term Outcome of Adjunct Foam Sclerotherapy for Varicose Veins in Patients Subjected to RFA at Dhulikhel Hospital, Nepal","authors":"R. Karmacharya, B. Shrestha, A. Singh, N. Chandi, N. Bhandari","doi":"10.1155/2019/4956437","DOIUrl":"https://doi.org/10.1155/2019/4956437","url":null,"abstract":"Background Varicose veins are dilated, tortuous, superficial veins usually seen on lower limbs. Various surgical modalities are available for varicose veins including open surgery (Trendelenburg operation), Endovenous Laser Ablation (EVLA), Radiofrequency Ablation (RFA) and Sclerotherapy. The aim of this study is to look for the outcome of adjunct sclerotherapy for varicose veins done as an adjunct with Radio Frequency Ablation. Objective To know the possible outcome regarding benefits and complications of adjunct sclerotherapy with Radio Frequency Ablation. Methodology We combined Radio Frequency Ablation of varicose veins with necessary phlebectomy and perforator ligation and performed adjunct sclerotherapy for residual significant varicosities with polidocanol (2%) mixed with 2 ml NS and 2 cc of air (Tessari method) to patients undergoing varicose vein surgery in between 2016 and 2017. Records on complications were enquired immediately following surgery and on 1st follow up done within 3–5 days of the procedure. Results Among 256 limbs subjected to varicose veins surgery 51 limbs were given adjunct sclerotherapy. Among them, five limbs had perivenous spillage with some localized swelling while there was allergic reaction in one patient as immediate postprocedural complication. Nine limbs had painful thrombosed veins during early follow-up. Conclusions Adjunct sclerotherapy showed complication rate of roughly one tenth and one fifth of the treated cases in immediate and early postoperative follow-up.","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2019 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2019-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/4956437","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47018824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Clinical Rationale for the Sentry Bioconvertible Inferior Vena Cava Filter for the Prevention of Pulmonary Embolism.","authors":"Michael D Dake,&nbsp;Gary M Ansel,&nbsp;Matthew S Johnson,&nbsp;Robert Mendes,&nbsp;H Bob Smouse","doi":"10.1155/2019/5795148","DOIUrl":"https://doi.org/10.1155/2019/5795148","url":null,"abstract":"<p><p>The Sentry inferior vena cava (IVC) filter is designed to provide temporary protection against pulmonary embolism (PE) during transient high-risk periods and then to bioconvert after 60 days after implantation. At the time of bioconversion, the device's nitinol arms retract from the filtering position into the caval wall. Subsequently, the stable stent-like nitinol frame is endothelialized. The Sentry bioconvertible IVC filter has been evaluated in a multicenter investigational-device-exemption pivotal trial (NCT01975090) of 129 patients with documented deep vein thrombosis (DVT) or PE, or at temporary risk of developing DVT or PE, and with contraindications to anticoagulation. Successful filter conversion was observed in 95.7% of patients at 6 months (110/115) and 96.4% at 12 months (106/110). Through 12 months, there were no cases of symptomatic PE. The rationale for development of the Sentry bioconvertible device includes the following considerations: (1) the period of highest risk of PE for the vast majority of patients occurs within the first 60 days after an index event, with most of the PEs occurring in the first 30 days; (2) the design of retrievable IVC filters to support their removal after a transitory high-PE-risk period has, in practice, been associated with insecure filter dynamics and time-dependent complications including tilting, fracture, embolization, migration, and IVC perforation; (3) most retrievable IVC filters are placed for temporary protection, but for a variety of reasons they are not removed in any more than half of implanted patients, and when removal is attempted, the procedure is not always successful even with advanced techniques; and (4) analysis of Medicare hospital data suggests that payment for the retrieval procedure does not routinely compensate for expense. The Sentry device is not intended for removal after bioconversion. In initial clinical use, complications have been limited. Long-term results for the Sentry bioconvertible IVC filter are anticipated soon.</p>","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2019 ","pages":"5795148"},"PeriodicalIF":1.3,"publicationDate":"2019-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/5795148","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37381944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Response to: Comment on \"Effect of Exercise Intervention on Flow-Mediated Dilation in Overweight and Obese Adults: Meta-Analysis\".","authors":"Younsun Son,&nbsp;Minsoo Kang,&nbsp;Yoonjung Park","doi":"10.1155/2019/2470581","DOIUrl":"https://doi.org/10.1155/2019/2470581","url":null,"abstract":"","PeriodicalId":14448,"journal":{"name":"International Journal of Vascular Medicine","volume":"2019 ","pages":"2470581"},"PeriodicalIF":1.3,"publicationDate":"2019-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/2470581","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37053109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}